Crescent Biopharma Inc (CBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 114,162 | 25,885 | 21,030 | 2,399 | -15,516 |
| Operating Income | -103,318 | -25,885 | -21,030 | -2,399 | 15,516 |
| Interest Expense | 1,112 | 0 | 1,073 | 0 | 0 |
| Other Income | 1,229 | 1,278 | 313 | 55 | -2,726 |
| Pre-tax Income | -103,201 | -24,607 | -21,790 | -2,344 | 12,789 |
| Net Income Continuous | -105,201 | -24,607 | -21,790 | -2,344 | 12,789 |
| Net Income | $-105,201 | $-24,607 | $-21,790 | $-2,344 | $12,789 |
| EPS Basic Total Ops | -2.61 | -1.27 | -4.93 | -4.00 | 24.72 |
| EPS Basic Continuous Ops | -4.01 | -1.49 | -5.65 | -3.63 | 24.27 |
| EPS Diluted Total Ops | -2.61 | -1.27 | -4.93 | -4.00 | 24.72 |
| EPS Diluted Continuous Ops | -4.01 | -1.49 | -5.65 | -3.63 | 24.27 |
| EPS Diluted Before Non-Recurring Items | -4.01 | -1.27 | -4.93 | -4.00 | -11.00 |
| EBITDA(a) | $-114,108 | $-25,857 | $-21,030 | $-2,399 | $15,516 |